Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/13/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Neil L. Berinstein

Wrong Dr. Neil L. Berinstein?

Professor, Department of Immunolo...

Phone: (416) ***-****  HQ Phone
University of Toronto
Queen's Park Toronto
Queen's Park Toronto, Ontario M5S 2C5
Canada

Company Description: Established in 1827, the University of Toronto is Canada's largest and most influential university with almost 12,000 faculty and staff working at three campuses...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • MD
  • Medical Doctorate
    University of Manitoba
  • pre-medical degree
    University of Manitoba
  • M.D. Chief Scientific Officer
  • M.D.
  • MD Chief Scientific Officer
  • PhD
121 Total References
Web References
Faculty Directory
www.immunology.utoronto.ca, 13 Mar 2014 [cached]
Neil Berinstein, M.D.
Professor Department of Immunology
Immunovaccine : Science Advisory
www.imvaccine.com, 28 Dec 2013 [cached]
Dr. Neil Berinstein
...
Dr. Neil Berinstein Science Advisory Board
Dr. Berinstein obtained his Medical Doctoral Degree at the University of Manitoba and completed training programs at the University of Toronto in Internal Medicine and Medical Oncology and at Stanford University in the area of Immunotherapy for cancer. Dr. Berinstein was a founding director of the Advanced Therapeutics Program at the Toronto-Sunnybrook Regional Cancer Centre with a long track record in fundamental research and a significant publication record in the area of normal and malignant B cell biology and cancer immunotherapy. Dr. Berinstein was Global Program Head of Sanofi Pasteur's cancer vaccine program from 1998-2009. He is a Full Professor in the Department of Medicine at the University of Toronto and is currently the Director of Translational Research at the Ontario Institute for Cancer Research. He is a member of the Executive Committee of the Cancer Research Institute Cancer Immunotherapy Consortium. He has published over 100 research papers and a similar number of research abstracts.
Scientific Advisory Board
www.biovest.com, 9 Dec 2013 [cached]
Neil L. Berinstein, M.D., Professor of Medicine, University of Toronto and Director of Translational Research, Ontario Institute for Cancer Research - Dr. Berinstein is a global pioneer in cancer vaccines, having formerly served as Assistant Vice President and Global Program Leader at Sanofi Pasteur, leading the development of Sanofi's cancer vaccines both strategically and operationally. He currently serves as part of the Executive Steering Committee of the Cancer Research Institute-sponsored Cancer Immunotherapy Consortium and was formerly a member and leader of the scientific review committee of the Leukemia Research Fund. Dr. Berinstein is the recipient of numerous grants in his research career and has published six book chapters, and over 100 peer-reviewed, invited or review papers to date.
Neil L. Berinstein, ...
www.cancerresearch.org, 24 Sept 2013 [cached]
Neil L. Berinstein, M.D.
Ontario Institute for Cancer Research
IRX Therapeutics | Making Cancer Treatments Better
www.irxtherapeutics.com, 17 June 2013 [cached]
Neil L. Berinstein, MD
...
NEIL L. BERINSTEIN, MD was appointed Chief Scientific Officer in January 2010. Dr. Berinstein, a global pioneer in cancer vaccines, worked with IRX as a consultant prior to his appointment. Prior to joining IRX, Dr. Berinstein served as Assistant Vice President and Global Program Leader at sanofi pasteur where he was in charge of leading the development of sanofi's cancer vaccines both strategically and operationally. Dr. Berinstein was responsible for interacting with international collaborators and leading researchers who were collaborating with sanofi pasteur either at pre-clinical or clinical levels. He saw to completion several multi-center phase I and phase II studies in Canada and the U.S. in colorectal and melanoma projects.
Dr. Berinstein currently holds multiple academic and professional positions, including Professor in the department of medicine, University of Toronto, and Active staff at the Odette Cancer Center of the Sunnybrook Health Science Center. He was the vice-president of the Cancer Vaccine Consortium sponsored by the Sabin Institute and more recently is part of the executive steering committee of the Cancer Research Institute (CRI)-sponsored Cancer Vaccine Consortium. He was formerly a member and leader of the scientific review committee of the Leukemia Research Fund.
Dr. Berinstein is the recipient of numerous grants in his research career and has published 6 book chapters, and over 100 peer-reviewed, invited or review papers to date. He received his pre-medical degree and Medical Doctorate from University of Manitoba and further specialty and research training at the University of Toronto and Stanford University.
Other People with the name "Berinstein":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.